Synthetic Opioids: Navigating the Changing Landscape of Opioid Use Disorder

Sponsor: UR Medicine Recovery Centr of Excellence This 35-minute self-paced module focuses on how primary care providers can navigate the changing landscape of opioid use disorder in relation to synthetic opioids. The module discusses synthetic overdose in relation to fentanyl and fentanyl analogs, as well as the dangers of xylazine. It provides treatment recommendations for patients who use synthetic opioids and overdose prevention strategies. For more information and to access click here

8-hour training for new or renewing DEA licenses

A new law soon goes into effect that requires new or renewing DEA licensees, as of June 27, 2023, to have completed a total of at least eight hours of training on opioid or other substance use disorders and the appropriate treatment of pain. Dr Yngvild Olsen, director of the Center for Substance Abuse Treatment at the Substance Abuse and Mental Health Services Administration, joins us to discuss the requirements going into effect, what should… Read more »

Half and Half X-Waiver Training Includes 4-Hour Live, Interactive Webinar

Live portion of the 8-hour X-waiver course Sponsor: American Osteopathic Academy of Addiction Medicine How it Works: When you have completed the entire free course, you will receive a certificate of completion. Physicians will then be able to apply for the waiver to prescribe buprenorphine. All other eligible providers can apply for the waiver after completing an additional 16-hour course . Providers eligible include: MDs, DOs, PAs, APRNs (NP, CNM, CNS, CRNA) To register and… Read more »

Half and Half X-Waiver Training Includes 4-Hour Live, Interactive Webinar

Sponsor: American Osteopathic Academy of Addiction Medicine In accordance with 2021 changes in practice guidelines for administering buprenorphine for the treatment of opioid use disorder, physician assistants are required to apply to the Drug Enforcement Agency for a waiver to prescribe buprenorphine. To treat more than 30 patients, however, providers must complete 24 hours of specialized training to prescribe buprenorphine, one of three medications approved by the FDA for the treatment of opioid use disorder…. Read more »

Contingency Management Provider Training

Sponsor: UVM Center on Rural Addiction To receive CME credit for this video, please complete the interactive version within the UVM CME portal. For instructions on how to complete this process, please visit: Use of cocaine and methamphetamine is rising across the country resulting in a wave of overdose deaths that is truly alarming. The ability to help people with issues around cocaine and stimulant use is hampered by the limited number of treatments… Read more »

NASW-NYS: Adolescents and Addiction: Trends, Treatment Approaches, and Developmental Considerations

Sponsor: Social Worker Online CE Institute Self-study Adolescence is a time of constant and significant change. In fact, most people will never experience a more dramatic change than when in their adolescence. So, what’s changing? Everything! Adolescents are simultaneously experiencing biological, psychological, social, and role changes, meaning that their bodies, brains, emotions, relationships, and everything in between are in a state of flux and growth. Substance use during adolescence further complicates – and even disrupts… Read more »

Medication Assisted Treatment: The Stigma, Treatment Availability, Barriers & Strategies – Presented by the NASW New Jersey Chapter

Sponsor: Social Worker Online CE Institute Self-study The number of patients presenting with Substance Use Disorders (SUD) more specifically Opioid Use Disorders (OUD) is increasing across settings. Social workers can use existing skills to diagnose, treat and collaborate with other healthcare providers to increase access to evidence-based treatment modalities such as Medication Assisted Treatment (MAT). Faculty: Anna Murawska, MSW, LCSW, LCADC Anna Murawska, MSW, LCSW, LCADC graduated Summa Cum Laude with Bachelor of Arts degree… Read more »

Words Matter – Terms to Use and Avoid When Talking About Addiction: A CME/CE Activity

Sponsor: National Institute on Drug Abuse self-paced activity with CME/CE released July 15, 2021; Expiration date for CME/CE – September 15, 2023 This CME/CE activity informs clinicians on how they can show leadership in how language can destigmatize the disease of addiction. It is focused on using person-first language, as well as terms to avoid to reduce stigma and negative bias when discussing addiction. Target Audience This activity is intended for physicians, physician assistants, pharmacists,… Read more »

Myth-Busting HCV Treatment: Demystifying HCV Treatment in At-Risk Populations

Sponsor: New England AIDS Education and Training Center Recorded on January 11, 2022 Part 3 of the “Myth-Busting HCV Treatment Series” explored the advances in the treatment of HCV to the clinical management of PWID and SUD and various monitoring strategies that can be used during HCV treatment and follow-up for hard-to-reach populations. Speaker:  Marguerite Beiser, NP, Director of HCV Services, Boston Health Care for the Homeless Program Topics: Harm Reduction/Safe Injection Hepatitis C Substance use… Read more »

Myth-Busting HCV Treatment: Interdisciplinary HCV Screening, Treatment and Follow-up

Sponsor: New England AIDS Education and Training Center Recorded on December 7, 2021: this recording is NOT certified for continuing education credit. Recorded discussion of the role of the interdisciplinary team in completing the essential components of HCV treatment assessment, service delivery for marginalized populations, and outreach to individuals experiencing SUD. Speakers from the Boston Health Care for the Homeless Program: Savanna Shores, RN, BSN, HCV Team Nurse Giavanna Wilson, Case Manager, HCV Services Khadija… Read more »